Norman, Katy C.
O’Dwyer, David N.
Salisbury, Margaret L.
DiLillo, Katarina M.
Lama, Vibha N.
Xia, Meng
Gurczynski, Stephen J.
White, Eric S.
Flaherty, Kevin R.
Martinez, Fernando J.
Murray, Susan
Moore, Bethany B.
Arnold, Kelly B.
Article History
Received: 17 January 2020
Accepted: 18 May 2020
First Online: 21 July 2020
Competing interests
: K.C.N., D.N.O., K.M.D., V.N.L., M.X., S.J.G, E.S.W., S.M., B.B.M., and K.B.A. report no competing interests. M.L.S. reports compensation for participation on a scientific advisory board, speaking, and consultancy for Boehringer Ingelheim Pharmaceuticals, Inc, unrelated to this manuscript. K.R.F. reports grants and consulting fees from Boehringer Ingelheim, grants and consulting fees from Roche/Genentech, and consulting fees from Veracyte, Fibrogen, Sanofi-Genzyme, and Celgene, outside of this project. F.J.M. has received personal fees from Forest, Janssen, GlaxoSmithKline, Nycomed/Takeda, Amgen, AstraZeneca, Boehringer Ingelheim, Ikaria/Bellerophon, Genentech, Novartis, Pearl, Pfizer, Roche, Sunovion, Theravance, Axon, CME Incite, California Society for Allergy and Immunology, Annenberg, Integritas, InThough, Miller Medical, National Association for Continuing Education, Paradigm, Peer Voice, UpToDate, Haymarket Communications, Western Society of Allergy and Immunology, Informa, Bioscale, Unity Biotechnology, ConCert, Lucid, Methodist Hospital, Prime, WebMD, Bayer, Ikaria, Kadmon, Vercyte, American Thoracic Society, Academic CME, Falco, Axon Communication, Johnson & Johnson, Clarion, Continuing Education, Potomac, Afferent, and Adept; and has collected nonfinancial support from Boehringer Ingelheim, Centocor, Gilead, and Biogen/Stromedix; and declares other interests with Mereo, Boehringering Ingelheim, and Centocor. All are outside of this project.